3,839
Views
3
CrossRef citations to date
0
Altmetric
Oncology

A review of the cost-effectiveness of genetic testing for germline variants in familial cancer

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 19-33 | Received 04 Apr 2022, Accepted 23 Nov 2022, Published online: 16 Dec 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.